LILLIAN BRUNER: Open Payments
NPI 1922570142 · KIRKSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 24 payments from 14 companies in 2025. Trend: 2023 $720 · 2024 $389 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Viatris Specialty LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Lundbeck LLC | 2 | $31 |
| Grifols USA, LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: REXULTI, YUPELRI, BREZTRI, Prolastin-C Liquid, AUSTEDO XR, ZEPBOUND, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
